Evidence map›Paper›PMID 31923258›Full record

ArticlePloS one2020

Novel broad-spectrum activity-based probes to profile malarial cysteine proteases.

Michele S Y Tan, Dara Davison, Mateo I Sanchez, Bethany M Anderson, Stephen Howell, Ambrosius Snijders, Laura E Edgington-Mitchell, Edgar Deu

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Targeting theHeliyon · 2022
    Review
  8. Review
  9. Discovery ofFrontiers in pharmacology · 2022
    Article
  10. Chemoproteomics for Plasmodium Parasite Drug Target Discovery.Chembiochem : a European journal of chemical biology · 2021
    Review
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Michele S Y TanThe Francis Crick Institute, London, United Kingdom.ORCID 0000-0002-3747-2365
Dara DavisonThe Francis Crick Institute, London, United Kingdom.
Mateo I SanchezDepartment of Genetics, Stanford School of Medicine, Stanford, California, United States of America.ORCID 0000-0003-1359-6969
Bethany M AndersonDepartment of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville Victoria, Australia.
Stephen HowellThe Francis Crick Institute, London, United Kingdom.
Ambrosius SnijdersThe Francis Crick Institute, London, United Kingdom.
Laura E Edgington-MitchellDepartment of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville Victoria, Australia.ORCID 0000-0002-6810-6149
Edgar DeuThe Francis Crick Institute, London, United Kingdom.ORCID 0000-0002-1852-4828
The Francis Crick Institute · GBThe University of Melbourne · AUStanford Medicine · US

Funding

Wellcome Trust 099950
6 · The paper itself

Abstract

Clan CA cysteine proteases, also known as papain-like proteases, play important roles throughout the malaria parasite life cycle and are therefore potential drug targets to treat this disease and prevent its transmission. In order to study the biological function of these proteases and to chemically validate some of them as viable drug targets, highly specific inhibitors need to be developed. This is especially challenging given the large number of clan CA proteases present in Plasmodium species (ten in Plasmodium falciparum), and the difficulty of designing selective inhibitors that do not cross-react with other members of the same family. Additionally, any efforts to develop antimalarial drugs targeting these proteases will also have to take into account potential off-target effects against the 11 human cysteine cathepsins. Activity-based protein profiling has been a very useful tool to determine the specificity of inhibitors against all members of an enzyme family. However, current clan CA proteases broad-spectrum activity-based probes either target endopeptidases or dipeptidyl aminopeptidases, but not both subfamilies efficiently. In this study, we present a new series of dipeptydic vinyl sulfone probes containing a free N-terminal tryptophan and a fluorophore at the P1 position that are able to label both subfamilies efficiently, both in Plasmodium falciparum and in mammalian cells, thus making them better broad-spectrum activity-based probes. We also show that some of these probes are cell permeable and can therefore be used to determine the specificity of inhibitors in living cells. Interestingly, we show that the choice of fluorophore greatly influences the specificity of the probes as well as their cell permeability.

Indexed as

AnimalsAntimalarialsCell Membrane PermeabilityCysteine ProteasesCysteine Proteinase InhibitorsHumansMalariaMolecular ProbesPlasmodium falciparumSulfonesTryptophanAntimalarialsCysteine ProteasesCysteine Proteinase Inhibitorsdivinyl sulfoneMolecular ProbesSulfonesTryptophan

Identifiers

PMID31923258
PMCPMC6953825
OpenAlexW2999745513

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.